SCHEMBL8038586

SCHEMBL8038586

C=CCNc1nc(-c2ccc(Cl)cc2)nc(CC)c1C(=O)OCC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 4/20 0.43
LMNA P02545 4/20 0.43
TSHR P16473 3/20 0.43
RXRA P19793 2/20 0.42
NR4A2 P43354 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
FOS P01100 1/20 0.41
JUN P05412 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8037000 0.88 RXRA (0.47) ALDH1A1NPSR1MEN1MAPTKMT2A
SCHEMBL8040593 0.83 TSHR (0.47) ALDH1A1NPSR1MEN1MAPTKMT2A
SCHEMBL8040307 0.81 GABRA2 (0.49) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL8034844 0.78 CASP3 (0.46) ALDH1A1NPSR1MEN1MAPTKMT2A
SCHEMBL8037266 0.76 GABRA2 (0.45) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL8038397 0.74 TARBP2 (0.49) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL8042776 0.73 TSHR (0.48) ALDH1A1NPSR1MAPTKDM4ELMNA
SCHEMBL8040651 0.73 ADORA3 (0.47) ALDH1A1NPSR1MAPTKDM4ELMNA
SCHEMBL8037289 0.72 GABRA2 (0.44) ALDH1A1MEN1MAPTKMT2AKDM4E
SCHEMBL8034443 0.72 TSHR (0.53) ALDH1A1NPSR1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080242-A1 SUBSTITUTED 4-AMINOPYRIMIDINE-5-CARBOXYLIC ACID AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed